1654
R. Rajaganesh et al. / Carbohydrate Research 345 (2010) 1649–1657
(m, 1H), 4.65–4.70 (m, 1H), 4.20–4.22 (m, 1H), 3.46–3.53 (m, 3H),
2.09 (s, 3H), 2.07 (s, 3H), 2.04 (s, 3H), 1.33 (d, J 5.1 Hz, 3H). 13C NMR
(75 MHz, CDCl3): dC 169.0, 169.4, 168.8, 102.7, 99.8, 92.2, 78.2,
71.8, 71.3, 67.8, 20.6 (3C), 19.8.
3.38–3.48 (m, 2H), 2.04 (s, 3H), 2.05 (d, 3H), 1.56–1.61 (m, 2H),
1.34–1.41 (m, 2H), 0.88 (t, J 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3):
dC 170.2, 169.6, 133.3, 117.5, 102.6, 100.2, 78.0, 72.1, 71.9, 70.2,
68.1, 66.5, 36.0, 20.7 (2C), 17.4, 13.8. Anal. Calcd for C17H26O8: C,
56.97; H, 7.31. Found: C, 57.31; H, 7.15.
3.3.2. 1,2,3-Tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose
(3b)
3.4.4. 2-Propyn-1-yl 2,3-di-O-acetyl-4,6-O-butylidene-b-D-
glucopyranoside (4d)
From 4,6-O-butylidene-D-glucopyranose (2b) (2.5 g, 10.60
mmol) using anhyd NaOAc (2 g, 243 mmol) in Ac2O (12.5 mL,
132 mmol).
From 1,2,3-tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose (3b)
(3.60 g, 10 mmol), propargyl alcohol (0.84 mL, 15 mmol) and BF3ꢀ
White solid (3.56 g, 90%); mp 110–112 °C;. 1H NMR (300 MHz,
CDCl3): dH 5.67 (d, J 3.6 Hz, 1H), 4.96–5.03 (m, 1H), 4.60 (m, 1H),
4.14–4.44 (m, 2H), 4.05–4.19 (m, 1H), 3.38–3.84 (m, 2H), 2.02 (s,
3H),1.99 (s, 3H), 1.56 (m, 2H), 1.34 (m, 2H), 0.85 (t, J 8 Hz, 3H).
13C NMR (75 MHz, CDCl3): dC 169.9 169.4, 168.8, 102.7, 92.2,
71.8, 71.2, 67.8, 67.1, 35.9, 20.6, 20.5, 17.3, 13.7.
OEt2 (3.52 mL, 25 mmol).
White solid (2.56 g, 72%); mp 102–104 °C; 1H NMR (300 MHz,
CDCl3): dH 5.15 (t, J 9.3 Hz, 1H), 4.88 (t, J 8.1 Hz, 1H), 4.72 (d, J
7.8 Hz, 1H), 4.43 (t, J 5.1 Hz, 1H), 4.27 (d, J 2.4 Hz, 2H), 4.11–
4.16 (m, 1H), 3.31–3.51 (m, 3H), 2.39 (t, J 2.4 Hz, 1H), 1.99 (d,
6H), 1.51–1.54 (m, 2H), 1.30–1.37 (m, 2H), 0.82 (t, J 7.5 Hz,
3H). 13C NMR (75 MHz, CDCl3): dC 170.1, 169.7, 102.6, 98.9,
78.2, 77.9, 76.6, 75.4, 71.8, 71.9, 68.0, 66.6, 56.1, 36.0, 20.7,
17.4, 13.8. Anal. Calcd for C17H24O8: C, 57.30; H, 6.79. Found:
C, 57.18; H, 6.93.
3.4. General method of synthesis of O-glycosides (4a–h)
To a mixture of 4,6-O-protected-1,2,3-tri-O-acetyl-b-D-gluco-
pyranose (3a–b, 10 mmol) and the alcohol (15 mmol) under
nitrogen atmosphere was added Et3N (5 mmol) in DCM (20 mL)
followed by BF3ꢀOEt2 (25 mmol) in DCM (5 mL) over 30 min. The
reaction mixture was then kept stirring until the TLC showed com-
pletion of the reaction. A Satd aq NaHCO3 (20 mL) was added, and
the reaction mixture was then extracted with EtOAc (30 mL ꢂ 2).
The organic layer was dried over anhyd MgSO4 followed by column
chromatographic purification on silica gel to give the correspond-
ing O-glycosides (4a–h).
3.4.5. Phenyl 2,3-di-O-acetyl-4,6-O-butylidene b-D-gluco-
pyranoside (4e)
From 1,2,3-tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose (3b)
(3.60 g, 10 mmol), phenol (1.41 mL, 15 mmol) and BF3ꢀOEt2 (3.52 mL,
25 mmol).
White solid (1.84 g, 45%); mp 156–158 °C; 1H NMR (300 MHz,
CDCl3): dH 7.27–7.33 (m, 2H), 7.05–7.10 (m, 1H), 6.96–6.99 (m,
2H), 5.20–5.32 (m, 2H), 5.13 (d, J 7.5 Hz, 1H), 4.53 (t, J 5.1 Hz,
1H), 4.22–4.26 (m, 1H), 3.49–3.63 (m, 3H), 2.06 (s, 6H), 1.60 (m,
2H), 1.35–1.45 (m, 2H), 0.89 (t, J 7.2 Hz, 3H). 13C NMR (75 MHz,
CDCl3): dC 170.2, 169.6, 156.9, 129.6 (2C), 123.4, 117.0 (2C),
102.7, 99.6, 77.8, 72.0, 71.8, 68.0, 66.7, 36.0, 20.7 (2C), 17.4, 13.8.
Anal. Calcd for C20H26O8: C, 60.90; H, 6.64. Found: C, 61.32; H, 6.84.
3.4.1. 2-Propen-1-yl 2,3-di-O-acetyl-4,6-O-ethylidene-b-D-
glucopyranoside (4a)
From 1,2,3-tri-O-acetyl-4,6-O-ethylidene-b-D-glucopyranose (3a)
(3.32 g, 10 mmol), allyl alcohol (0.97 mL, 15 mmol) and BF3ꢀOEt2
(3.52 mL, 25 mmol).
White solid (1.78 g, 54%); mp 118–120 °C. 1H NMR (300 MHz,
CDCl3): dH 5.18–5.30 (m, 1H), 4.94–5.00 (m, 3H), 4.67–4.70 (m,
1H), 4.57 (d, J 7.8 Hz, 1H), 4.28–4.35 (m, 1H), 4.07–4.21 (m, 3H),
3.53–3.61 (m, 3H), 2.17 (s, 3H), 2.06 (s, 3H) 1.32 (d, J 4.8 Hz, 3H).
13C NMR (75 MHz, CDCl3,): dC 170.2, 169.5, 133.3, 117.9, 100.2,
99.7, 77.9, 72.3, 71.9, 70.1, 66.30, 62.5, 20.8 (2C), 20.7, 20.2. Anal.
Calcd for C15H22O8: C, 54.54; H, 6.71. Found: C, 54.72; H, 6.94.
3.4.6. 4-Methylphenyl 2,3-di-O-acetyl-4,6-O-butylidene b-D-
glucopyranoside (4f)
From 1,2,3-tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose (3b)
(3.60 g, 10 mmol), p-methylphenol (1.62 mL, 15 mmol) and BF3ꢀOEt2
(3.52 mL, 25 mmol).
White solid (1.78 g, 42%); mp 146–148 °C; 1H NMR (300 MHz,
CDCl3): dH 7.07–7.10 (m, 2H), 6.82–6.88 (m, 2H), 5.17–5.31 (m,
2H), 5.07 (d, J 7.5 Hz, 1H), 4.52 (t, J 5.1 Hz, 1H), 4.20–4.25 (m,
1H), 3.43–3.62 (m, 3H), 2.30 (s, 3H), 2.06 (s, 3H), 2.08 (s, 3H)
1.58–1.62 (m, 2H), 1.32–1.42 (m, 2H), 0.89 (t, J 7.2 Hz, 3H). 13C
NMR (75 MHz, CDCl3): dC 170.3, 169.6, 154.8, 132.9, 130.1, 127.5,
117.0, 115.6, 102.7, 100.0, 77.8, 72.1, 71.9, 68.1, 66.7, 36.0, 20.8,
20.7, 20.6, 17.4, 13.9. Anal. Calcd for C21H28O8: C, 61.75; H, 6.91.
Found: C, 61.41; H, 7.22.
3.4.2. 2-Propyn-1-yl 2,3-di-O-acetyl-4,6-O-ethylidene-b-D-
glucopyranoside (4b)
From 1,2,3-tri-O-acetyl-4,6-O-ethylidene-b-D-glucopyranose (3a)
(3.32 g, 10 mmol), propargyl alcohol (0.84 mL, 15 mmol) and BF3ꢀ
OEt2 (3.52 mL, 25 mmol).
White solid (2.30 g, 70%); mp 136–138 °C; 1H NMR (300 MHz,
CDCl3): dH 5.24 (t, J 9.3 Hz, 1H), 4.92–4.98 (t, J 9.0 Hz, 1H), 4.78
(d, J 7.8 Hz, 1H), 4.65–4.70 (q, J 4.8 Hz, 1H), 4.34–4.35 (s, 2H),
4.17–4.22 (m, 1H), 3.53–3.60 (m, 1H), 3.39–3.50 (m, 2H), 2.47 (t,
J 2.4 Hz, 1H), 2.04 (s, 3H), 2.06 (s, 3H), 1.32 (d, J 4.8 Hz, 3H). 13C
NMR (75 MHz, CDCl3): dC 170.2, 169.7, 99.7, 98.8, 78.1, 77.8,
75.4, 72.0, 71.8, 68.0, 66.4, 56.1, 20.8 (2C), 20.2. Anal. Calcd for
3.4.7. 4-Ethylphenyl 2,3-di-O-acetyl-4,6-O-butylidene-b-D-
glucopyranoside (4g)
From 1,2,3-tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose (3b)
(3.60 g, 10 mmol), p-ethylphenol (1.83 mL, 15 mmol) and BF3ꢀOEt2
C15H20O8: C, 54.87; H, 6.14. Found: C, 54.41; H, 5.96.
(3.52 mL, 25 mmol).
White solid (2.15 g, 49%); mp 122–124 °C; 1H NMR (300 MHz,
CDCl3): dH 7.10–7.13 (m, 2H), 6.88–6.91 (m, 2H), 5.18–5.31 (m,
2H), 5.08 (d, J 7.2 Hz, 1H), 4.52 (t, J 5.1 Hz, 1H), 4.20–4.25 (m,
1H), 3.50–3.62 (m, 3H), 2.56–2.61 (q, J 7.5 Hz, 2H), 2.04 (s, 3H),
2.07 (s, 3H), 1.59–1.62 (m, 2H), 1.35–1.45 (m, 2H), 1.19 (t, J
7.5 Hz, 3H), 0.89 (t, J 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): dC
170.2, 169.6, 154.9, 139.3, 128.8 (2C), 117.0 (2C), 102.7, 100.0,
77.8, 72.1, 71.9, 68.1, 66.7, 36.0, 28.1, 20.7 (2C), 17.4, 15.7, 13.8.
Anal. Calcd for C22H30O8: C, 62.55; H, 7.16. Found: C, 62.73; H, 7.45.
3.4.3. 2-Propen-1-yl 2,3-di-O-acetyl-4,6-O-butylidene-b-D-
glucopyranoside (4c)
From
1,2,3-tri-O-acetyl-4,6-O-butylidene-b-D-glucopyranose
(3b) (3.60 g, 10 mmol), allyl alcohol (0.97 mL, 15 mmol) and
BF3ꢀOEt2 (3.52 mL, 25 mmol).
White solid (2.39 g, 67%); mp 120–124 °C; 1H NMR (300 MHz,
CDCl3): dH 5.77–5.90 (m, 1H), 5.17–5.33 (m, 3H), 4.93–5.00 (m,
1H), 4.57 (d, J 7.8 Hz, 1H), 4.49 (t, J 5.1 Hz, 1H), 4.29–4.35 (m,
1H), 4.17–4.22 (m, 1H), 4.05–4.11 (m, 1H), 3.50–3.59 (m, 1H),